Volume 22, Number 12—December 2016
Schmallenberg Virus in Zoo Ruminants, France and the Netherlands
Highlight and copy the desired format.
|EID||Laloy E, Braud C, Bréard E, Kaandorp J, Bourgeois A, Kohl M, et al. Schmallenberg Virus in Zoo Ruminants, France and the Netherlands. Emerg Infect Dis. 2016;22(12):2201-2203. https://dx.doi.org/10.3201/eid2212.150983|
|AMA||Laloy E, Braud C, Bréard E, et al. Schmallenberg Virus in Zoo Ruminants, France and the Netherlands. Emerging Infectious Diseases. 2016;22(12):2201-2203. doi:10.3201/eid2212.150983.|
|APA||Laloy, E., Braud, C., Bréard, E., Kaandorp, J., Bourgeois, A., Kohl, M....Chai, N. (2016). Schmallenberg Virus in Zoo Ruminants, France and the Netherlands. Emerging Infectious Diseases, 22(12), 2201-2203. https://dx.doi.org/10.3201/eid2212.150983.|
To the Editor: Schmallenberg virus (SBV), a new orthobunyavirus of the family Bunyaviridae, emerged in August 2011 in northwestern Europe (1) and spread to most parts of Europe by Culicoides vectors (2). Most infections are asymptomatic in adult ruminants, yet fever, milk drop, and diarrhea have been reported (1). SBV is responsible for congenital malformations in newborn calves, lambs, and goat kids and has also been associated with abortions and early embryonic losses (3). The virus affects domestic livestock, but antibodies to SBV have also been found in free-ranging wild ruminants in several European countries (3–6) and in wild and exotic ruminants kept in captivity in the United Kingdom and in Austria (3–5). We carried out a study to investigate the exposure to SBV of wild and exotic ruminants born in Europe and kept in 1 zoological park in France and 1 in the Netherlands.
We tested 42 serum samples (from 39 animals) collected between 2011 and 2014 in the Safaripark Beekse Bergen (SPBB, Hilvarenbeek, the Netherlands) and 18 serum samples (from 15 animals) collected between 2013 and 2015 in the Ménagerie du Jardin des Plantes, Muséum National d’Histoire Naturelle (MJP, Paris, France). First, we determined the presence of SBV-specific antibodies in the samples by ELISA (ELISA ID Screen SBV Competition; ID Vet, Grabels, France) and by virus neutralization test (VNT) according to a protocol previously described (7). The 2 methods gave identical results except for 5 samples found negative by ELISA and positive by VNT. Thirty (55.6%) of 54 animals were found to be seropositive by VNT, which is regarded as the standard for SBV detection (Table). Antibodies to SBV were found in 11 (73.3%) of 15 animals from MJP and 19 (48.7%) of 39 animals from SPBB. Positive results were found in samples collected every year during 2011–2015; the earliest positive result was found in a sample collected in September 2011 (SPBB).
Several seropositive ruminants from MJP were either born in Paris or transferred to Paris from another park in Europe before 2010, which suggests that they were exposed to SBV in Paris. SBV antibodies were found in 3 consecutive samples collected in October 2011, September 2012, and March 2013 from a sable antelope (Hippotragus niger niger) in SPBB but also in 3 consecutive samples collected in October 2013, February 2014, and September 2014 in a bharal (Pseudois nayaur) from MJP. These data suggest that SBV antibodies can persist for >1 year in these 2 species.
We then performed SBV-specific quantitative reverse transcription PCR targeting the small segment (8) of the virus on every sample. One sample from an SBV seronegative blue wildebeest (Connochaetes taurinus taurinus) collected in September 2011 in SPBB was positive (quantitation cycle value = 30), whereas the other samples were negative. We also performed several in-house conventional reverse transcription PCR targeting the small, large, and medium segments on the positive sample, which enabled us to retrieve a 2,866-bp partial sequence from the medium segment (deposited in GenBank under accession no. KR828816) and a 1,374-bp partial sequence from the L segment (deposited in GenBank under accession no. KR828815). Genetic analyses based on BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) revealed that the large and medium partial sequences had 100% and 99.79% identity, respectively, with SBV sequences from cows (GenBank accession nos. KM047418 and KP731872, respectively).
Subcutaneous inoculation of serum to adult IFNAR−/− mice, which have been reported to be susceptible to SBV infection (9,10), did not trigger any clinical sign or seroconversion. No genome could be amplified from their blood.
According to the medical records of SPBB, no clinical signs possibly related to an SBV infection were observed in the ruminants during the period studied. Abortions were reported in MJP in 2 bharals in 2011 and 2012 and in 1 West Caucasian tur (Capra caucasica caucasica) in 2013, but no correlation could be drawn between these abortions and the SBV serologic results.
This study demonstrates the circulation of SBV in 18 wild and exotic ruminant species kept in captivity in the Netherlands and in France during 2011–2015. Exposure to the virus may occur even in an urban area (such as central Paris). We report evidence of SBV viremia in a blue wildebeest that was seronegative by ELISA and VNT when the serum was collected. SBV RNA has previously been found in an elk (6), but the duration of viremia was not determined. Further investigations are required to determine whether zoo ruminants may play a role in dissemination of SBV.
We are grateful to Dylan Duby and Claire Réjaud. We thank Manjula Deville and Marc Chodkiewicz for editing the manuscript.
This study was supported and financed by the Muséum National d’Histoire Naturelle (grant identification: ATM—Collections vivantes 2014 and 2015).
- Hoffmann B, Scheuch M, Höper D, Jungblut R, Holsteg M, Schirrmeier H, et al. Novel orthobunyavirus in cattle, Europe, 2011. Emerg Infect Dis. 2012;18:469–72.
- Wernike K, Conraths F, Zanella G, Granzow H, Gache K, Schirrmeier H, et al. Schmallenberg virus-two years of experiences. Prev Vet Med. 2014;116:423–34.
- Steinrigl A, Schiefer P, Schleicher C, Peinhopf W, Wodak E, Bagó Z, et al. Rapid spread and association of Schmallenberg virus with ruminant abortions and foetal death in Austria in 2012/2013. Prev Vet Med. 2014;116:350–9.
- EFSA (European Food Safety Authority). Schmallenberg virus: state of the art. EFSA journal. 2014;12(5):3681 [cited 2015 May 17]. http://www.efsa.europa.eu/en/efsajournal/pub/3681.htm
- Molenaar FM, La Rocca SA, Khatri M, Lopez J, Steinbach F, Dastjerdi A. Exposure of Asian elephants and other exotic ungulates to Schmallenberg virus. PLoS One. 2015;10:e0135532.
- Larska M, Krzysiak M, Smreczak M, Polak MP, Zmudziński JF. First detection of Schmallenberg virus in elk (Alces alces) indicating infection of wildlife in Białowieża National Park in Poland. Vet J. 2013;198:279–81.
- Bréard E, Lara E, Comtet L, Viarouge C, Doceul V, Desprat A, et al. Validation of a commercially available indirect ELISA using a nucleocapside recombinant protein for detection of Schmallenberg virus antibodies. PLoS One. 2013;8:e53446.
- Bilk S, Schulze C, Fischer M, Beer M, Hlinak A, Hoffmann B. Organ distribution of Schmallenberg virus RNA in malformed newborns. Vet Microbiol. 2012;159:236–8.
- Wernike K, Breithaupt A, Keller M, Hoffmann B, Beer M, Eschbaumer M. Schmallenberg virus infection of adult type I interferon receptor knock-out mice. PLoS One. 2012;7:e40380.
- Ponsart C, Pozzi N, Bréard E, Catinot V, Viard G, Sailleau C, et al. Evidence of excretion of Schmallenberg virus in bull semen. Vet Res (Faisalabad). 2014;45:37.
- Table. Results of virus neutralization testing for Schmallenberg virus among exotic and wild ruminants from 2 zoological parks in France and the Netherlands, 2011–2015
Please use the form below to submit correspondence to the authors or contact them at the following address:
Eve Laloy, UMR Virologie 1161 (ANSES/INRA/ENVA), Laboratoire de Santé animale, ANSES, 14 rue Pierre et Marie Curie, 94700 Maisons-Alfort, France
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: November 18, 2016
- Page last updated: November 18, 2016
- Page last reviewed: November 18, 2016
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)